BioSpace News Archive

The Childhood Arthritis and Rheumatology Research Alliance, also known as CARRA, announced the appointment of Mathieu Nelessen as Chief Executive Officer, effective January 9, 2023.

Paragonix Technologies, Inc. achieves a historic milestone in Hawaii with the first-ever utilization of its advanced lung preservation technology, the Paragonix LUNGguard™ system, which protected, monitored and geo-tracked a pair of donor lungs throughout its lengthy voyage to California.

Kurome Therapeutics, Inc., a late pre clinical stage biotech company developing novel IRAK1/4 inhibitors for oncology indications, today announced two abstracts have been accepted for oral and poster presentations at the 64th American Society of Hematology (ASH) Annual Meeting and Exposition, to be held December 9-13, 2022, in New Orleans.

Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company, today announced the completion of drug administration in an open-label study of simufilam for Alzheimer’s disease.

The Lung Cancer Research Foundation® is pleased to announce the awardees of its 2022 Scientific Grant Program.

ABK Biomedical, Inc., an innovative medical device company dedicated to the research, development, and commercialization of advanced imageable embolic therapies, today announced an oversubscribed USD 30 million Series C financing.

Cleerly, the company creating a new standard of care for heart disease, announced it has appointed Udo Hoffmann, MD, MPH, as chief scientific officer.

OMNY, Inc. (d/b/a OMNY Health), a leader in compliant data and platform solutions for connecting healthcare stakeholders, today announced a $17 million Series B round led by Chicago Pacific Founders (CPF). Dr. Vance Vanier, MD, Co-Founder and Co-Managing Partner of CPF will join the OMNY Board of Directors.

MyMD Pharmaceuticals, Inc.® is presenting data at the 2022 British Society for Immunology Congress in Liverpool, England.

Gerresheimer AG, a leading provider of healthcare & beauty solutions and drug delivery systems for pharma, biotech and cosmetics, reaffirmed its growth agenda and increased its revenue and adjusted EBITDA guidance.